Ani Pharmaceuticals (ANIP) Short-term Investments (2020 - 2026)

Ani Pharmaceuticals (ANIP) has 6 years of Short-term Investments data on file, last reported at $36000.0 in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 5.88% year-over-year to $36000.0; the trailing twelve-month figure through Mar 2026 stood at $36000.0 (up 5.88% YoY), and the FY2025 full-year result was $36000.0, up 9.09% from the prior year.
• Short-term Investments steadied at $36000.0 in Q1 2026, from $36000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $5.0 million in Q4 2022 to a low of $33000.0 in Q4 2024.
• A 4-year average of $1.8 million and a median of $36000.0 in 2025 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments climbed 0.1% in 2022 and gained 9.09% in 2025, its largest moves.
• Tracing ANIP's Short-term Investments over 4 years: stood at $5.0 million in 2022, then slumped by 99.34% to $33000.0 in 2024, then advanced by 9.09% to $36000.0 in 2025, then changed by 0.0% to $36000.0 in 2026.
• Business Quant data shows ANIP's Short-term Investments at $36000.0 in Q1 2026, $36000.0 in Q4 2025, and $36000.0 in Q3 2025.